Your browser doesn't support javascript.
loading
Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.
Garzon-Muvdi, Tomas; Theodros, Debebe; Luksik, Andrew S; Maxwell, Russell; Kim, Eileen; Jackson, Christopher M; Belcaid, Zineb; Ganguly, Sudipto; Tyler, Betty; Brem, Henry; Pardoll, Drew M; Lim, Michael.
Afiliação
  • Garzon-Muvdi T; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Theodros D; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Luksik AS; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Maxwell R; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Kim E; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Jackson CM; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Belcaid Z; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Ganguly S; Department of Cancer Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Tyler B; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Brem H; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Pardoll DM; Department of Cancer Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Lim M; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Oncotarget ; 9(29): 20681-20697, 2018 Apr 17.
Article em En | MEDLINE | ID: mdl-29755681

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article